Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers.
D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000037:antagonists & inhibitors*; D004311:Double-Blind Method; D005167:Factor VII / Q000494:pharmacology*; D015942:Factor VIIa; D065427:Factor Xa Inhibitors; D006801:Humans; D008297:Male; D009844:Oligosaccharides / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics; D010314:Partial Thromboplastin Time; D011517:Prothrombin Time; D011994:Recombinant Proteins / Q000494:pharmacology*; D013917:Thrombin / Q000378:metabolism
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D009844:Oligosaccharides; D011994:Recombinant Proteins; C479958:idraparinux; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa; D013917:Thrombin